D'INCALCI, MAURIZIO

D'INCALCI, MAURIZIO  

Dipartimento Scienze Biomediche  

Mostra records
Risultati 1 - 20 di 504 (tempo di esecuzione: 0.025 secondi).
Titolo Data di pubblicazione Autore(i) File
3-methyladenine-DNA-glycosylase and O-6-alkyl guanine-DNA-alkyltransferase activities and sensitivity to alkylating agents in human cancer cell lines 1-gen-1996 Damia, G; Imperatori, L; Citti, L; Mariani, L; D'Incalci, M
34. Trabectedin and indole-3-carbinol combination in heavily pretreated metastatic breast cancer: Results of a pilot clinical study 1-gen-2014 Zambelli, A; Tancredi, R; Negri, S; Cattrini, C; Ponchio, L; Frascaroli, M; Da Prada GA Fregoni, V; Pavesi, L; Riccardi, A; Zucchett, M; Nerini, If; D'Incalci, M
3D Mass Spectrometry Imaging Reveals a Very Heterogeneous Drug Distribution in Tumors 1-gen-2016 Giordano, S; Morosi, L; Veglianese, P; A Licandro, S; Frapolli, R; Zucchetti, M; Cappelletti, G; Falciola, L; Pifferi, V; Visentin, S; D'Incalci, M; Davoli, E
A biodistribution study of PEGylated PCL-based nanoparticles in C57BL/6 mice bearing B16/F10 melanoma 1-gen-2014 Lupi, M; Colombo, C; Frapolli, R; Ferrari, R; Sitia, L; Dragoni, L; Bello, E; Licandro, Sa; Falcetta, F; Ubezio, P; Bigini, P; Salmona, M; D'Incalci, M; Morbidelli, M; Moscatelli, D
A comprehensive safety analysis confirms rhabdomyolysis as an uncommon adverse reaction in patients treated with trabectedin 1-gen-2012 Grosso, F; D'Incalci, M; Cartoafa, M; Nieto, A; Fernandez-Teruel, C; Alfaro, V; Lardelli, P; Roy, E; Gomez, J; Kahatt, C; Soto-Matos, A; Judson, I
A covalent PIN1 inhibitor selectively targets cancer cells by a dual mechanism of action 1-gen-2017 Campaner, E; Rustighi, A; Zannini, A; Cristiani, A; Piazza, S; Ciani, Y; Kalid, O; Golan, G; Baloglu, E; Shacham, S; Valsasina, B; Cucchi, U; Pippione, Ac; Lolli, Ml; Giabbai, B; Storici, P; Carloni, P; Rossetti, G; Benvenuti, F; Bello, E; D'Incalci, M; Cappuzzello, E; Rosato, A; Del Sal, G
A FILTER INCUBATION METHOD FOR THE DETERMINATION OF POTENTIALLY CROSSLINKABLE SITES IN DNA IN MAMMALIAN-CELLS 1-gen-1985 D'Incalci, M; Szmigiero, L; Erickson, Lc; Hartley, Ja; Kohn, Kw
A first in human phase I study of the proteasome inhibitor CEP-18770 in patients with advanced solid tumours and multiple myeloma 1-gen-2013 Gallerani, E; Zucchetti, M; Brunelli, D; Marangon, E; Noberasco, C; Hess, D; Delmonte, A; Martinelli, G; Bohm, S; Driessen, C; De Braud, F; Marsoni, S; Cereda, R; Sala, F; D'Incalci, M; Sessa, C
A Nanostructured Matrices Assessment to Study Drug Distribution in Solid Tumor Tissues by Mass Spectrometry Imaging 1-gen-2017 Giordano, S; Pifferi, V; Morosi, L; Morelli, M; Falciola, L; Cappelletti, G; Visentin, S; Licandro, Sa; Frapolli, R; Zucchetti, M; Pastorelli, R; Brunelli, L; D'Incalci, M; Davoli, E
A novel taxane active against an orthotopically growing human glioma xenograft 1-gen-2001 Laccabue, D; Tortoreto, M; Veneroni, S; Perego, P; Scanziani, E; Zucchetti, M; Zaffaroni, M; D'Incalci, M; Bombardelli, E; Zunino, F; Pratesi, G
A phase II randomised (calibrated design) study on the activity of the single-agent trabectedin in metastatic or locally relapsed uterine leiomyosarcoma 1-gen-2018 Gadducci, A; Grosso, F; Scambia, G; Raspagliesi, F; Colombo, N; Grignani, G; Casali, P; Sanfilippo, R; Buonadonna, A; Santoro, A; Bruzzone, M; Artioli, G; Lorusso, D; Biagioli, E; Fossati, R; Galli, F; Negri, E; Rulli, E; Torri, V; D’Incalci, M
A prognostic regulatory pathway in stage I epithelial ovarian cancer: new hints for the poor prognosis assessment 1-gen-2016 Calura, E; Paracchini, L; Fruscio, R; Difeo, A; Ravaggi, A; Peronne, J; Martini, P; Sales, G; Beltrame, L; Bignotti, E; Tognon, G; Milani, R; Clivio, L; Dell'Anna, T; Cattoretti, G; Katsaros, D; Sartori, E; Mangioni, C; Ardighieri, L; D'Incalci, M; Marchini, S; Romualdi, C
A Review of Trabectedin (ET-743): A Unique Mechanism of Action 1-gen-2010 D'Incalci, M; Galmarini, C.
A Review of Trabectedin (ET-743): A Unique Mechanism of Action 1-gen-2010 D'Incalci, M; Galmarini, Cm
A Specific miRNA Signature Correlates With Complete Pathological Response to Neoadjuvant Chemoradiotherapy in Locally Advanced Rectal Cancer 1-gen-2012 Scarpati, Gd; Falcetta, F; Carlomagno, C; Ubezio, P; Marchini, S; De Stefano, A; Singh, Vk; D'Incalci, M; De Placido, S; Pepe, S
A specific miRNA signature correlates with complete pathological response to neoadjuvant chemoradiotherapy in locally advanced rectal cancer 1-gen-2011 Scarpati, Gd; Carlomagno, C; Marchini, S; Ubezio, P; Falcetta, F; D'Incalci, M; De Placido, S; Sabbatino, F; Fusciello, C; Pepe, S
A Systems Biology Approach to Characterize the Regulatory Networks Leading to Trabectedin Resistance in an In Vitro Model of Myxoid Liposarcoma 1-gen-2012 Uboldi, S; Calura, E; Beltrame, L; Nerini, If; Marchini, S; Cavalieri, D; Erba, E; Chiorino, G; Ostano, P; D'Angelo, D; D'Incalci, M; Romualdi, C
A systems biology approach to investigate the mechanism of action of trabectedin in a model of myelomonocytic leukemia 1-gen-2016 Mannarino, L; Paracchini, L.; Craparotta, I.; Romano, M.; Marchini, S.; Gatta, R.; Erba, E.; Clivio, L.; Romualdi, Chiara; D'Incalci, Maurizio; Beltrame, L.; Pattini, L.
Activation of TGF-Beta Pathway Through Mir-181a and Psmad-2 Overexpression Drives Resistance To Neoadjuvant Chemotherapy in High Grade Serous Advanced Ovarian Cancer 1-gen-2015 Petrillo, M; Marchini, S; Romualdi, C; Beltrame, L; Martinelli, E; Difeo, A; D'Incalci, M; Zannoni, Gf; Scambia, G
Activity and safety of trabectedin in patients with sarcomatoid / biphasic malignant pleural mesothelioma (MPM) 1-gen-2015 Cortinovis, Dl; Hollander, Lh; Floriani, Ic; Grosso, F; Marinello, A; Ceresoli, Gl; Pacchetti, I; Zucali, Pa; D'Incalci, M; Canova, S; Abbate, Mi; Ugo, F; Vukcaj, S; Bidoli, P